PDF icon PDF herunterladen
Open Access
CC BY-NC-ND 4.0 · Journal of Coloproctology 2023; 43(01): 007-011
DOI: 10.1055/s-0043-1764198
Original Article

Fecal Incontinence or Pelvic Organ Prolapse Among Women with Premature Ovarian Insufficiency

Júlia Ferreira Fante 
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Universidade de Campinas, Campinas, SP, Brazil
,
Cássia Raquel Teatin Juliato
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Universidade de Campinas, Campinas, SP, Brazil
,
Cristina Laguna Benetti-Pinto
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Universidade de Campinas, Campinas, SP, Brazil
,
Luiz Gustavo Oliveira Brito
1   Department of Obstetrics and Gynecology, School of Medical Sciences, Universidade de Campinas, Campinas, SP, Brazil
› Institutsangaben
Funding None.
› Weitere Informationen
Auch verfügbar aufeRef
  Lizenzen und Reprints
Preview

Abstract

Objectives To assess the status of the pelvic floor muscle (PFM) of premature ovarian insufficiency women (POI women) and the incidence of fecal incontinence (FI) and pelvic organ prolapse (POP).

Methods A secondary analysis of a cross-sectional study with 150 women with POI was performed. Pelvic floor muscle assessment was performed with the PERFECT scale. The subscales POPDI-6 and CRADI-8 of the questionnaire Pelvic Floor Distress Inventory-20 (PFDI-20) were used for pelvic floor symptoms focused on FI and POP. Moreover, FI and POP were also assessed as dichotomous variables (yes/no).

Results Women with FI and POP did not present differences in the PFM assessment across P (p = 0.61), E (p = 0.78), R (p = 0.22), and F (p = 0.79) variables when compared with women with POI; no differences were also seen between women with and without POP according the pelvic muscles: P (p = 0.91), E (p = 0.99), R (p = 0.62), and F (p = 0.10). Women with FI and POP presented higher scores in all PFDI-20 subscales and total score when compared with the control group (p < 0.05).

Conclusions Pelvic floor muscle assessment within POI women with or without FI or POP did not differ. However, PF symptoms are more severe in the FI or POP groups.

Keywords

fecal incontinence - pelvic organ prolapse - premature ovarian insufficiency - PFDI-20 - pelvic floor muscles


Publikationsverlauf

Eingereicht: 30. September 2022

Angenommen: 23. Januar 2023

Artikel online veröffentlicht:
22. März 2023

© 2023. Sociedade Brasileira de Coloproctologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • References

  • 1 Webber L, Davies M, Anderson R. et al; European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod 2016; 31 (05) 926-937
    CrossrefPubMedSuche in Google Scholar
  • 2 Robinson D, Cardozo LD. The role of estrogens in female lower urinary tract dysfunction. Urology 2003; 62 (4, Suppl 1) 45-51
    CrossrefPubMedSuche in Google Scholar
  • 3 Sultan AH, Monga A, Lee J, Emmanuel A, Norton C, Santoro G, Hull T, Berghmans B, Brody S, Haylen BT. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female anorectal dysfunction. Int Urogynecol J 2017; Jan; 28 (01) 5-31
    CrossrefPubMedSuche in Google Scholar
  • 4 Bach FL, Sairally BZF, Latthe P. Effect of oestrogen therapy on faecal incontinence in postmenopausal women: a systematic review. Int Urogynecol J 2020 Jul;31(07):1289–1297. doi: 10.1007/s00192-020-04252-1. Epub 2020 Mar 4
  • 5 Brito LGO, Pereira GMV, Moalli P, Shynlova O, Manonai J, Weintraub AY, Deprest J, Bortolini MAT. Age and/or postmenopausal status as risk factors for pelvic organ prolapse development: systematic review with meta-analysis. Int Urogynecol J 2022; Jan; 33 (01) 15-29
    CrossrefPubMedSuche in Google Scholar
  • 6 Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 2010; Jan; 21 (01) 5-26
    CrossrefPubMedSuche in Google Scholar
  • 7 Fante JF, Brito LGO, Teatin-Juliato CR, Benetti-Pinto CL. Can hormone therapy modify pelvic floor muscle assessment and symptoms within women with premature ovarian insufficiency?. Eur J Obstet Gynecol Reprod Biol 2020; 252: 624-625
    CrossrefPubMedSuche in Google Scholar
  • 8 Fante JF, Machado HDC, Juliato CRT, Benetti-Pinto CL, Brito LGO. Pelvic floor disorders in women with premature ovarian insufficiency: a cross-sectional study. Menopause 2020; 27 (04) 450-458
    CrossrefPubMedSuche in Google Scholar
  • 9 Laycock, J and Jerwood, D (2001). Pelvic floor muscle assessment: The PERFECT Scheme', Physiotherapy, 87, 12, 631-642. DOI:10.1016/S0031-9406(05)61108-X
  • 10 Arouca MA, Duarte TB, Lott DA, Magnani PS, Nogueira AA, Rosa-E-Silva JC, Brito LG. Validation and cultural translation for Brazilian Portuguese version of the Pelvic Floor Impact Questionnaire (PFIQ-7) and Pelvic Floor Distress Inventory (PFDI-20). Int Urogynecol J 2016; Jul; 27 (07) 1097-1106
    CrossrefPubMedSuche in Google Scholar
  • 11 Nygaard I, Barber MD, Burgio KL. et al; Pelvic Floor Disorders Network. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008; 300 (11) 1311-1316
    CrossrefPubMedSuche in Google Scholar
  • 12 de Oliveira SC, Pinto-Neto AM, Conde DM, Góes JR, Santos-Sá D, Costa-Paiva L. [Fecal incontinence in postmenopausal women: prevalence, severity and associated factors]. Arq Gastroenterol 2006; 43 (02) 102-106
    PubMedSuche in Google Scholar
  • 13 Horst W, do Valle JB, Silva JC, Gascho CLL. Pelvic organ prolapse: prevalence and risk factors in a Brazilian population. Int Urogynecol J 2017; Aug; 28 (08) 1165-1170
    CrossrefPubMedSuche in Google Scholar
  • 14 Gabra MG, Tessier KM, Fok CS, Nakib N, Oestreich MC, Fischer J. Pelvic organ prolapse and anal incontinence in women: screening with a validated epidemiology survey. Arch Gynecol Obstet 2022; 306 (03) 779-784
    CrossrefPubMedSuche in Google Scholar
  • 15 Camtosun A, Sen I, Onaran M, Aksakal N, Özgür Tan M, Bozkirli I. An evaluation of fecal incontinence in women with urinary incontinence. Eur Rev Med Pharmacol Sci 2016; May; 20 (10) 1918-1922
    PubMedSuche in Google Scholar
  • 16 Staller K, Townsend MK, Khalili H, Mehta R, Grodstein F, Whitehead WE, Matthews CA, Kuo B, Chan AT. Menopausal Hormone Therapy Is Associated With Increased Risk of Fecal Incontinence in Women After Menopause. Gastroenterology 2017; Jun; 152 (08) 1915-1921.e1
    CrossrefPubMedSuche in Google Scholar